APA (7th ed.) Citation

M, S., F, C., A, O., LH, C., Singer, M., Coluzzi, F., . . . Clapp, L. H. (2005). Reversal of life-threatening, drug-related potassium-channel syndrome by glibenclamide. Lancet, 365(9474), 1873. https://doi.org/10.1016/s0140-6736(05)66619-6

Chicago Style (17th ed.) Citation

M, Singer, Coluzzi F, O'Brien A, Clapp LH, Mervyn Singer, Flaminia Coluzzi, Alastair O'Brien, and Lucie H. Clapp. "Reversal of Life-threatening, Drug-related Potassium-channel Syndrome by Glibenclamide." Lancet 365, no. 9474 (2005): 1873. https://doi.org/10.1016/s0140-6736(05)66619-6.

MLA (9th ed.) Citation

M, Singer, et al. "Reversal of Life-threatening, Drug-related Potassium-channel Syndrome by Glibenclamide." Lancet, vol. 365, no. 9474, 2005, p. 1873, https://doi.org/10.1016/s0140-6736(05)66619-6.